肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理

2020-11-20 欧洲肿瘤内科学会 Ann Oncol . 2020 Nov 20;

抗癌药物

2020年11月，欧洲肿瘤内科学会(ESMO)发布了抗癌药物相关性皮肤毒性的预防和管理指南。多数接受抗癌治疗的患者需要帮助预防和减轻不良反应事件(AEs)和应对疾病本身。本文主要针对抗癌药物相关性皮肤

中文标题：

2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理

英文标题：

Prevention and Management of Dermatological Toxicities Related to Anticancer Agents: ESMO Clinical Practice Guidelines

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-11-20

简要介绍：

2020年11月，欧洲肿瘤内科学会(ESMO)发布了抗癌药物相关性皮肤毒性的预防和管理指南。多数接受抗癌治疗的患者需要帮助预防和减轻不良反应事件(AEs)和应对疾病本身。本文主要针对抗癌药物相关性皮肤毒性的预防和管理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理 .pdf)] GetToolGuiderByIdResponse(projectId=1, id=e0cf31c002018913, title=2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理, enTitle=Prevention and Management of Dermatological Toxicities Related to Anticancer Agents: ESMO Clinical Practice Guidelines, guiderFrom=Ann Oncol . 2020 Nov 20;, authorId=0, author=, summary=2020年11月，欧洲肿瘤内科学会(ESMO)发布了抗癌药物相关性皮肤毒性的预防和管理指南。多数接受抗癌治疗的患者需要帮助预防和减轻不良反应事件(AEs)和应对疾病本身。本文主要针对抗癌药物相关性皮肤, cover=https://img.medsci.cn/2020121/1606753182515_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Fri Nov 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，欧洲肿瘤内科学会(ESMO)发布了抗癌药物相关性皮肤毒性的预防和管理指南。多数接受抗癌治疗的患者需要帮助预防和减轻不良反应事件(AEs)和应对疾病本身。本文主要针对抗癌药物相关性皮肤毒性的预防和管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2041, tagName=抗癌药物)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2041, guiderKeyword=抗癌药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3320, appHits=116, showAppHits=0, pcHits=584, showPcHits=3204, likes=7, shares=15, comments=18, approvalStatus=1, publishedTime=Mon Nov 30 00:34:04 CST 2020, publishedTimeString=2020-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 30 23:47:41 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 09:59:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理 .pdf)])
2020 ESMO临床实践指南：抗癌药物相关性皮肤毒性的预防和管理 .pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2164166, encodeId=e58d216416606, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Sun Oct 22 09:02:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1194204, encodeId=418411942041d, content=hhxx, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2eb5485299, createdName=ms3000001297972652, createdTime=Wed Feb 16 22:40:32 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918687, encodeId=d36c91868e58, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8d25454380, createdName=ms7000000868105864, createdTime=Thu Jan 21 14:08:42 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907673, encodeId=b20990e673f9, content=皮肤毒性管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df795328139, createdName=可乐的妈妈, createdTime=Sun Dec 13 21:25:01 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905545, encodeId=1b8d905545ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00135442068, createdName=ms4000001301120711, createdTime=Sun Dec 06 23:53:27 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2023-10-22 MOMOlew 来自广东省

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2164166, encodeId=e58d216416606, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Sun Oct 22 09:02:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1194204, encodeId=418411942041d, content=hhxx, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2eb5485299, createdName=ms3000001297972652, createdTime=Wed Feb 16 22:40:32 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918687, encodeId=d36c91868e58, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8d25454380, createdName=ms7000000868105864, createdTime=Thu Jan 21 14:08:42 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907673, encodeId=b20990e673f9, content=皮肤毒性管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df795328139, createdName=可乐的妈妈, createdTime=Sun Dec 13 21:25:01 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905545, encodeId=1b8d905545ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00135442068, createdName=ms4000001301120711, createdTime=Sun Dec 06 23:53:27 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2022-02-16 ms3000001297972652

    hhxx

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2164166, encodeId=e58d216416606, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Sun Oct 22 09:02:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1194204, encodeId=418411942041d, content=hhxx, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2eb5485299, createdName=ms3000001297972652, createdTime=Wed Feb 16 22:40:32 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918687, encodeId=d36c91868e58, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8d25454380, createdName=ms7000000868105864, createdTime=Thu Jan 21 14:08:42 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907673, encodeId=b20990e673f9, content=皮肤毒性管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df795328139, createdName=可乐的妈妈, createdTime=Sun Dec 13 21:25:01 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905545, encodeId=1b8d905545ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00135442068, createdName=ms4000001301120711, createdTime=Sun Dec 06 23:53:27 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-01-21 ms7000000868105864

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2164166, encodeId=e58d216416606, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Sun Oct 22 09:02:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1194204, encodeId=418411942041d, content=hhxx, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2eb5485299, createdName=ms3000001297972652, createdTime=Wed Feb 16 22:40:32 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918687, encodeId=d36c91868e58, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8d25454380, createdName=ms7000000868105864, createdTime=Thu Jan 21 14:08:42 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907673, encodeId=b20990e673f9, content=皮肤毒性管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df795328139, createdName=可乐的妈妈, createdTime=Sun Dec 13 21:25:01 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905545, encodeId=1b8d905545ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00135442068, createdName=ms4000001301120711, createdTime=Sun Dec 06 23:53:27 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-12-13 可乐的妈妈

    皮肤毒性管理

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2164166, encodeId=e58d216416606, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05465507066, createdName=MOMOlew, createdTime=Sun Oct 22 09:02:20 CST 2023, time=2023-10-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1194204, encodeId=418411942041d, content=hhxx, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2eb5485299, createdName=ms3000001297972652, createdTime=Wed Feb 16 22:40:32 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918687, encodeId=d36c91868e58, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8d25454380, createdName=ms7000000868105864, createdTime=Thu Jan 21 14:08:42 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907673, encodeId=b20990e673f9, content=皮肤毒性管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df795328139, createdName=可乐的妈妈, createdTime=Sun Dec 13 21:25:01 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905545, encodeId=1b8d905545ff, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00135442068, createdName=ms4000001301120711, createdTime=Sun Dec 06 23:53:27 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-12-06 ms4000001301120711

    好

    0

以上为热门评论，梅斯医学App还有更多内容